Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: About 25% of pregnant women experience bleeding in the early stage, and half of them eventually progress to pregnancy loss. Progesterone serves as a useful biomarker to predict miscarriage in threatened miscarriage, yet its performance is still debated.
Aim: To evaluate the performance of single serum progesterone predicting miscarriage in early pregnant patients with threatened miscarriage.
Method: The online database was searched to yield the literature using the terms of 'Abortion', 'Miscarriage', and 'serum Progesterone', including PubMed, Scopus, Embase, Cochrane library, and China national knowledge infrastructure. Receiver operating characteristic (ROC) curve, likelihood ratio (LLR) and diagnostic odds ratio (DOR) and 95% confidence interval (CI) were computed. Publication bias was assessed by the deeks funnel plot asymmetry test. Subgroup analyses were conducted according to the progesterone level (< 12 ng/mL), recruited location and region, progesterone measurement method, exogenous progesterone supplement and follow up.
Results: In total, 12 studies were eligible to be included in this study, with sample sizes ranging from 76 to 1087. The included patients' gestational age was between 4 and 12 weeks. No significant publication bias was detected from all included studies. The threshold of progesterone reported ranged from 8 to 30 ng/ml. The synthesized area under the ROC curve (0.85, 95% CI 0.81 to 0.88), positive LLR (6.2, 4.0 to 9.7) and DOR (18, 12 to 27) of single progesterone measurement distinguishing miscarriage were relatively good in early pregnant patients with threatened miscarriage. When the threshold of < 12 ng/mL was adapted, the progesterone provided a higher area under the ROC curve (0.90 vs. 0.78), positive LLR (8.3 vs. 3.8) and DOR (22 vs.12) than its counterpart (12 to 30 ng/mL).
Conclusion: Single progesterone measurement can act as a biomarker of miscarriage in early pregnant patients with threatened miscarriage, and it has a better performance when the concentration is <12 ng/mL.
Trial Registration: PROSPERO (CRD42021255382).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10863102 | PMC |
| http://dx.doi.org/10.1186/s12884-024-06303-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Bushenhuoxue formula improves prothrombotic state in recurrent spontaneous abortion: network pharmacology and experimental validation.
Drug Target Insights
August 2025
Department of Gynecology, Shanghai University of Traditional Chinese Medicine affiliated Shuguang Hospital Anhui Hospital, Anhui, Hefei - China.
Introduction: Bushenhuoxue formula is a traditional Chinese medicine formula with relatively safe clinical effects, but its mechanism in recurrent spontaneous abortion (RSA) is still unclear. Our present study used Network pharmacology an experimental validation to discuss how Bushenhuoxue formula improves prethrombotic state in RSA.
Materials And Methods: The active ingredients of Bushenhuoxue formula (Drug) were acquired from our previous study.
Predicting first-trimester pregnancy outcome in threatened miscarriage: A comparison of a multivariate logistic regression and machine learning models.
Radiography (Lond)
September 2025
Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Malta. Electronic address:
Introduction: Threatened miscarriage (TM), defined as first-trimester vaginal bleeding with a closed cervix and detectable fetal cardiac activity, affects up to 30 % of clinically recognised pregnancies and is linked to increased risk of adverse outcomes. This study evaluates the predictive value of first-trimester ultrasound (US) and biochemical (BC) markers in determining outcomes among women with TM symptoms.
Methods: This prospective cohort study recruited 118 women with viable singleton pregnancies (5 to 12 weeks' gestation) from Malta's national public hospital between January 2023 and June 2024.
A mathematical model for Zika virus disease: Intervention methods and control of affected pregnancies.
Math Biosci Eng
June 2025
Department of Mathematics and Computer Science, Wabash College, Crawfordsville, IN, USA.
Zika virus is spread to human populations primarily by Aedes aegypti mosquitoes, and Zika virus disease has been linked to a number of developmental abnormalities and miscarriages, generally coinciding with infection during early pregnancy. In this paper, we propose a new mathematical model for the transmission of Zika and study a range of control strategies to reduce the incidence of affected pregnancies in an outbreak. While most infectious disease models primarily focus on measures of the spread of the disease, our model is formulated to estimate the number of affected pregnancies throughout the simulated outbreak.
View Article and Find Full Text PDFDevelopment and validation of a postpartum cardiovascular disease risk prediction model in women incorporating reproductive and pregnancy-related predictors.
BMC Med
August 2025
Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham, UK.
Background: Each year, over 700,000 pregnancies occur in the UK, with up to 10% affected by complications such as hypertensive disorders of pregnancy and gestational diabetes mellitus. Pregnancy-related complications and reproductive factors are associated with an increased risk of cardiovascular disease (CVD) later in life. Our aim was to determine whether adding pregnancy factors to a prediction model with established CVD risk factors improves 10-year risk prediction of CVD in postpartum women, using QRISK®-3 as a benchmark model.
View Article and Find Full Text PDFDeep Learning Models: Their Relationship with Embryonic Euploidies and Reproductive Outcomes.
Genes (Basel)
August 2025
IVIRMA Global Research Alliance, IVIRMA Roma, 00161 Rome, Italy.
Embryo selection in in vitro fertilization (IVF) aims to prioritize embryos with the highest reproductive potential. While preimplantation genetic testing for aneuploidy (PGT-A) remains the gold standard for identifying euploid embryos, it is invasive and not universally applicable. Deep learning (DL)-based models, such as the intelligent data analysis (iDA) score, have emerged as non-invasive alternatives for embryo assessment.
View Article and Find Full Text PDF